COSCIENS Biopharma Inc.
CSCIF
$2.09
-$0.16-7.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.31M | 8.52M | 9.33M | 13.76M | 16.39M |
| Total Receivables | 1.26M | 1.61M | 2.78M | 1.86M | 2.47M |
| Inventory | 1.31M | 1.76M | 1.82M | 2.46M | 2.69M |
| Prepaid Expenses | 2.99M | 1.38M | 1.91M | 1.42M | 1.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 259.00K | 570.00K | 657.00K | 860.00K | 726.00K |
| Total Current Assets | 11.50M | 13.84M | 16.50M | 20.35M | 23.98M |
|
|
|||||
| Total Current Assets | 11.50M | 13.84M | 16.50M | 20.35M | 23.98M |
| Net Property, Plant & Equipment | 9.81M | 9.89M | 10.92M | 10.66M | 10.97M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 125.00K | 132.00K | 132.00K | 128.00K | 123.00K |
| Total Assets | 21.43M | 23.86M | 27.56M | 31.14M | 35.07M |
|
|
|||||
| Total Accounts Payable | 745.00K | 1.03M | 1.54M | 2.86M | 2.41M |
| Total Accrued Expenses | 1.14M | 923.00K | 1.53M | 1.90M | 2.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 215.00K | 212.00K | 209.00K | 253.00K | 271.00K |
| Total Finance Division Other Current Liabilities | 4.91M | 1.82M | 2.30M | 2.05M | 2.17M |
| Total Other Current Liabilities | 4.91M | 1.82M | 2.30M | 2.05M | 2.17M |
| Total Current Liabilities | 3.61M | 3.98M | 5.58M | 7.06M | 7.22M |
|
|
|||||
| Total Current Liabilities | 3.61M | 3.98M | 5.58M | 7.06M | 7.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.93M | 1.96M | 2.05M | 1.97M | 2.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.04M | 12.84M | 12.83M | 11.97M | 12.65M |
| Total Liabilities | 17.59M | 18.78M | 20.46M | 21.00M | 21.91M |
|
|
|||||
| Common Stock & APIC | 22.62M | 22.62M | 22.60M | 22.50M | 22.49M |
| Retained Earnings | -20.51M | -19.05M | -17.23M | -14.66M | -12.11M |
| Treasury Stock & Other | 1.73M | 1.51M | 1.72M | 2.30M | 2.79M |
| Total Common Equity | 3.84M | 5.08M | 7.10M | 10.14M | 13.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.84M | 5.08M | 7.10M | 10.14M | 13.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.84M | 5.08M | 7.10M | 10.14M | 13.16M |
|
|
|||||